EW

SEC source: 0001225208-26-008338 · doc4.xml · derivative · entry 3

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,095

Underlying: Common Stock · 619 shares

Expires 2027-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-26-008338 · doc4.xml · nonDerivative · entry 2

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,033.9103

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

SEC source: 0001225208-26-008338 · doc4.xml · nonDerivative · entry 1

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,652.9103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

SEC source: 0001225208-26-007812 · doc4.xml · nonDerivative · entry 2

Markowitz Wayne · CIK 0001991414 · CVP, JAPAC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,370.5581

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).

SEC source: 0001225208-26-007811 · doc4.xml · nonDerivative · entry 1

Dahl Andrew M. · CIK 0002022347 · SVP, Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,615.41

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).

SEC source: 0001225208-26-007812 · doc4.xml · nonDerivative · entry 1

Markowitz Wayne · CIK 0001991414 · CVP, JAPAC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,938.5581

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).

SEC source: 0001225208-26-007774 · doc4.xml · derivative · entry 3

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,714

Underlying: Common Stock · 619 shares

Expires 2027-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-26-007774 · doc4.xml · nonDerivative · entry 2

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,033.9103

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

SEC source: 0001225208-26-007774 · doc4.xml · nonDerivative · entry 1

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,652.9103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

SEC source: 0001225208-26-007775 · doc4.xml · nonDerivative · entry 1

Chopra Daveen · CIK 0001740963 · CVP, TMTT, Surgical & IHFM

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,926

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).

SEC source: 0001225208-26-007408 · doc4.xml · nonDerivative · entry 1

Dahl Andrew M. · CIK 0002022347 · SVP, Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,868.41

SEC source: 0001225208-26-007377 · doc4.xml · nonDerivative · entry 1

Bruls Annette · CIK 0002032351 · CVP, EMEACLA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,984

SEC source: 0001225208-26-007335 · doc4.xml · derivative · entry 4

Chopra Daveen · CIK 0001740963 · CVP, TMTT, Surgical & IHFM

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 31,800 shares

Expires 2027-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-26-007335 · doc4.xml · nonDerivative · entry 3

Chopra Daveen · CIK 0001740963 · CVP, TMTT, Surgical & IHFM

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,324

F2 · price: This transaction was executed in multiple trades at prices ranging from $90.645 to $91.640. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-26-007335 · doc4.xml · nonDerivative · entry 2

Chopra Daveen · CIK 0001740963 · CVP, TMTT, Surgical & IHFM

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,970

F1 · price: This transaction was executed in multiple trades at prices ranging from $91.660 to $91.975. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-26-007335 · doc4.xml · nonDerivative · entry 1

Chopra Daveen · CIK 0001740963 · CVP, TMTT, Surgical & IHFM

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,124

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-26-007332 · doc4.xml · nonDerivative · entry 1

Markowitz Wayne · CIK 0001991414 · CVP, JAPAC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,293.5581

SEC source: 0001225208-26-007065 · doc4.xml · derivative · entry 3

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,333

Underlying: Common Stock · 619 shares

Expires 2027-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-26-007065 · doc4.xml · nonDerivative · entry 2

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,033.9103

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

SEC source: 0001225208-26-007065 · doc4.xml · nonDerivative · entry 1

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,652.9103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

SEC source: 0001225208-26-006853 · doc4.xml · nonDerivative · entry 1

Markowitz Wayne · CIK 0001991414 · CVP, JAPAC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,533.5581

SEC source: 0001225208-26-006777 · doc4.xml · derivative · entry 3

Markowitz Wayne · CIK 0001991414 · CVP, JAPAC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,628

Underlying: Common Stock · 9,628 shares

Expires 2030-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-26-006777 · doc4.xml · nonDerivative · entry 2

Markowitz Wayne · CIK 0001991414 · CVP, JAPAC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,679.8708

SEC source: 0001225208-26-006777 · doc4.xml · nonDerivative · entry 1

Markowitz Wayne · CIK 0001991414 · CVP, JAPAC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,307.8708

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-26-006743 · doc4.xml · nonDerivative · entry 3

Zovighian Bernard J · CIK 0001665141 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 8,915.6499

SEC source: 0001225208-26-006743 · doc4.xml · nonDerivative · entry 2

Zovighian Bernard J · CIK 0001665141 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 11,836.201

SEC source: 0001225208-26-006743 · doc4.xml · nonDerivative · entry 1

Zovighian Bernard J · CIK 0001665141 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,845

SEC source: 0001225208-26-006591 · doc4.xml · nonDerivative · entry 1

Bruls Annette · CIK 0002032351 · CVP, EMEACLA

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,628

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).

SEC source: 0001225208-26-006576 · doc4.xml · derivative · entry 3

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,952

Underlying: Common Stock · 619 shares

Expires 2027-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-26-006576 · doc4.xml · nonDerivative · entry 2

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,033.9103

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

SEC source: 0001225208-26-006576 · doc4.xml · nonDerivative · entry 1

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,652.9103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

SEC source: 0001225208-26-006578 · doc4.xml · derivative · entry 4

Mistras Theodora · CIK 0002013495 · CVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,325

Underlying: Common Stock · 12,325 shares

Expires not disclosed

F4 · derivative.exercise_price: Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on July 9, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards.

F4 · derivative.expiration_date: Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on July 9, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards.

SEC source: 0001225208-26-006578 · doc4.xml · derivative · entry 3

Mistras Theodora · CIK 0002013495 · CVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,800

Underlying: Common Stock · 61,800 shares

Expires 2033-07-08

F3 · derivative.exercise_date: These options were granted on July 9, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

SEC source: 0001225208-26-006578 · doc4.xml · nonDerivative · entry 2

Mistras Theodora · CIK 0002013495 · CVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,920

F2 · shares: These restricted stock units were granted on July 9, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

SEC source: 0001225208-26-006578 · doc4.xml · nonDerivative · entry 1

Mistras Theodora · CIK 0002013495 · CVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,595

F1 · shares: These restricted stock units were granted on July 9, 2026, under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest as follows: 43.75% on the first anniversary of May 29, 2026 (the "Start Date"), 50% on the second anniversary of the Start Date, and the remaining 6.25% on the third anniversary of the Start Date.

SEC source: 0001225208-26-006535 · doc4.xml · nonDerivative · entry 1

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,033.9103

F1 · kind: Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).

SEC source: 0001225208-26-006263 · doc4.xml · derivative · entry 3

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,571

Underlying: Common Stock · 619 shares

Expires 2027-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-26-006263 · doc4.xml · nonDerivative · entry 2

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,410.9103

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

F2 · price: This transaction was executed in multiple trades at prices ranging from $91.185 to $91.650. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-26-006263 · doc4.xml · nonDerivative · entry 1

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,029.9103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

SEC source: 0001225208-26-006103 · doc4.xml · nonDerivative · entry 1

Zovighian Bernard J · CIK 0001665141 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 11,516.5511

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.

SEC source: 0001225208-26-005647 · doc4.xml · nonDerivative · entry 1

Dahl Andrew M. · CIK 0002022347 · SVP, Corporate Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,334.0948

SEC source: 0001225208-26-005610 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 98,611

F1 · price: This transaction was executed in multiple trades at prices ranging from $86.27 to $86.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-26-005576 · doc4.xml · nonDerivative · entry 1

Chopra Daveen · CIK 0001740963 · CVP, TMTT & Surgical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,324

F1 · price: This transaction was executed in multiple trades at prices ranging from $84.6002 to $84.6050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-26-005464 · doc4.xml · derivative · entry 3

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,190

Underlying: Common Stock · 620 shares

Expires 2027-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-26-005464 · doc4.xml · nonDerivative · entry 2

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,410.9103

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

SEC source: 0001225208-26-005464 · doc4.xml · nonDerivative · entry 1

Lippis Daniel J. · CIK 0002004380 · CVP, TAVR

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 41,030.9103

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

SEC source: 0001225208-26-005463 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: No plan indicated

Ownership: Indirect · 401(k)

Disclosed balance after: 30,969.5756

SEC source: 0001225208-26-005463 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,798.2532

F1 · price: This transaction was executed in multiple trades at prices ranging from $81.975 to $82.260. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-26-005172 · doc4.xml · nonDerivative · entry 6

Zovighian Bernard J · CIK 0001665141 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 12,039.5511

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.

F4 · price: This transaction was executed in multiple trades at prices ranging from $77.375 to $78.360. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-26-005172 · doc4.xml · nonDerivative · entry 5

Zovighian Bernard J · CIK 0001665141 · Director · CEO

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust

Disclosed balance after: 47,545.5511

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.

F3 · price: This transaction was executed in multiple trades at prices ranging from $78.390 to $78.430. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.